Featured Research

from universities, journals, and other organizations

Researchers regenerate a fully functional bioengineered lacrimal gland

Date:
October 2, 2013
Source:
ResearchSEA
Summary:
Organ replacement regenerative therapy has been proposed as having the potential to enable the replacement of organs that have been damaged by disease, injury or aging. A research group signals a substantial advancement in the development of next-generation organ replacement regenerative therapies for dry eye disorders.

This image indicates the corneal surface and tear of the bioengineered lacrimal and harderian gland engrafted mice. Photographs represent the eye surface of mouse including normal mouse (upper left), lacrimal gland defected mouse (upper right), bioengineered lacrimal gland engrafted mouse (lower left) and bioengineered harderian gland engrafted mouse (lower right). This image clearly indicates that the engrafted bioengineered lacrimal and harderian gland has potential for tear secretion and protection of ocular surface.
Credit: Tsuji et al.

Organ replacement regenerative therapy has been proposed as having the potential to enable the replacement of organs that have been damaged by disease, injury or aging. A research group led by Professor Takashi Tsuji (Professor in the Research Institute for Science and Technology, Tokyo University of Science, and Director of Organ Technologies Inc.) has provided a proof-of-concept for bioengineered organ replacement as the next step for regenerative therapy.

Dr. Tsuji's research group (M. Hirayama et al.,) reports the successful orthotopic transplantation of a bioengineered lacrimal gland germ into an adult extra-orbital lacrimal gland defect model mouse, which mimics the corneal epithelial damage caused by lacrimal gland dysfunction. The bioengineered lacrimal gland germ and harderian gland germ both developed in vivo and achieved sufficient physiological functionality, including tear production in response to nervous stimulation and ocular surface protection. This study demonstrates the potential for bioengineered organ replacement to functionally restore the lacrimal gland.

This research was performed in collaboration with Professor Kazuo Tsubota (Department of Ophthalmology, Keio University School of Medicine, Japan).

BACKGROUND TO THE RESEARCH

The role of lacrimal gland. The lacrimal gland, which develops from its organ germ induced by an epithelial-mesenchymal interactions during embryogenesis, plays important roles in maintaining a healthy ocular surface via tear secretion. The mature lacrimal glands, which consist of acini enveloped by myoepithelial cells and a duct, form effective tear secretory systems under the control of the central nervous systems. Aqueous tear, which is secreted from the lacrimal glands, are composed of water and proteins. Tear lipids, which prevent the tear evaporation, are secreted by meibomian glands in humans and harderian glands in mice. Tears are indispensable for lid lubrication, protection of the epithelial surface and visual function.

The dry eye disease. Dry eye disease (DED), which is caused by tear shortage by the lacrimal gland dysfunction, is observed in Sjogren's syndrome and Stevens-Jonson syndrome, as well as other causes, including aging and long-term work with a visual display. DED, which causes corneal epithelial damages, results in a significant loss of vision, and decreased quality of life. It is estimated that more than 22 million in Japan and approximately 12% of American people >50 years old have DED. Current therapies for DED, including artificial tear solutions, are conservative. Several therapeutic approaches have been developed to restore lacrimal gland function, including heterotopic salivary gland transplantation and regenerative medicine.

Regeneration of lacrimal gland and harderian gland. We have developed an ex vivo cell manipulation method called "the organ germ method," which regenerates a bioengineered organ germ through the induction of the epithelial-mesenchymal interactions using epithelial cells and mesenchymal cells (Nature Methods 4, 227-30, 2007). Moreover, demonstrated the proof of concept for the regeneration of ectodermal organs such as teeth and hair follicles using this method (PNAS 106, 13475-13430, 2009, Nat.Commun. 3:784, 2012). These reports verified the concept of organ regeneration by the transplantation of bioengineered organ germ regeneration.

OUTLINE OF THE RESEARCH OUTCOME

During embryogenesis, the lacrimal gland develops into a functional, mature lacrimal gland with complete secretory structure, including acini, ducts and the nerve fibres from the lacrimal gland germ. In this study, we sought to achieve functional bioengineered lacrimal gland replacement via orthotopic engraftment of a bioengineered lacrimal gland germ into an extra-orbital lacrimal gland defect mouse model that mimics ocular surface damage by lacrimal gland dysfunction. In addition, we investigated whether we can regenerate the bioengineered harderian gland, which secretes the tear lipids to the ocular surface.

Generation and transplantation of the bioengineered lacrimal and harderian gland germs We successfully regenerated the bioengineered lacrimal and harderian gland germs, which could develop into secretory gland structure through branching morphogenesis, using the organ germ method. We also demonstrated that the bioengineered lacrimal and harderian gland germs could be engrafted in vivo at high frequency by transplanting them into an extra-orbital lacrimal gland defect mouse model. We confirmed the duct connection between the bioengineered gland and the recipients by injecting Evans blue and showing that the dye transferred from the recipient's lacrimal excretory duct to the bioengineered gland without leaking.

Histology of the bioengineered lacrimal and harderian glands For effective tear secretion, coordination between the lacrimal gland structures, such as acini and myoepithelial cells, and nerve innervations is important. The engrafted bioengineered lacrimal and harderian glands achieve a three-dimensional histology with nerve innervations. Moreover, the expression of lactoferrin, a protein secreted by the lacrimal gland, was found in the acini of bioengineered lacrimal gland. We also confirmed the lipids, which are secreted mainly by the harderian gland, were present in the acini of the bioengineered harderian glands. These results indicate that the bioengineered lacrimal and harderian glands are able to secrete the appropriate tear contents in response to neural stimulus.

Secretion of bioengineered tears and lipids Appropriate nervous control of tear fluid secretion is essential for the full function of the bioengineered lacrimal glands, and it is required to protect the ocular surface. In our study, the bioengineered lacrimal and harderian glands secreted transparent tears and turbid tears in response to cool cell activation on the ocular surface. In addition, the tear flow of the bioengineered lacrimal gland was equivalent to that of the glands of normal control mice. The lipid concentration of the tears from the bioengineered harderian gland was increased compared with that of the normal or bioengineered lacrimal gland engrafted mice. These results demonstrate that the bioengineered lacrimal and harderian glands displayed functional secretory ability under appropriate neural control.

Bioengineered lacrimal gland protects the ocular surface The goal of lacrimal gland regenerative therapy is to restore the damaged ocular surface caused by DED. Therefore, we analysed the corneal epithelial damage of the bioengineered lacrimal gland engrafted mice. The impaired area of the corneal epithelial surface in the bioengineered lacrimal gland engrafted mice was reduced compared to the lacrimal gland defect mice at 30 days after surgery. Chronic DED results in corneal epithelial thinning. In our study, the corneal thickness of the bioengineered lacrimal gland engrafted mice was maintained at the level of normal mice at 60 days after surgery. These results indicate that our bioengineered lacrimal gland successfully developed, achieved full lacrimal gland function and maintained a healthy ocular surface.

CONCLUSION

In conclusion, the bioengineered lacrimal gland germ and harderian gland germ both developed in vivo and achieved sufficient physiological functionality, including tear production, in response to nervous stimulation and ocular surface protection. This study is the first to demonstrate the potential for bioengineered organ replacement to functionally restore the lacrimal gland. In addition, we provided proof-of-concept for lipid secretory organ regeneration by regenerating the harderian gland, which secretes lipids that are critical for tear function. Further studies on the identification of stem cells, including adult tissue stem cells, embryonic stem cells and inductive pluripotent stem cells, as sources for bioengineered lacrimal and harderian gland germs will contribute to the development of lacrimal gland organ regeneration.


Story Source:

The above story is based on materials provided by ResearchSEA. Note: Materials may be edited for content and length.


Journal Reference:

  1. Masatoshi Hirayama, Miho Ogawa, Masamitsu Oshima, Yurie Sekine, Kentaro Ishida, Kentaro Yamashita, Kazutaka Ikeda, Shigeto Shimmura, Tetsuya Kawakita, Kazuo Tsubota, Takashi Tsuji. Functional lacrimal gland regeneration by transplantation of a bioengineered organ germ. Nature Communications, 2013; 4 DOI: 10.1038/ncomms3497

Cite This Page:

ResearchSEA. "Researchers regenerate a fully functional bioengineered lacrimal gland." ScienceDaily. ScienceDaily, 2 October 2013. <www.sciencedaily.com/releases/2013/10/131002102315.htm>.
ResearchSEA. (2013, October 2). Researchers regenerate a fully functional bioengineered lacrimal gland. ScienceDaily. Retrieved September 22, 2014 from www.sciencedaily.com/releases/2013/10/131002102315.htm
ResearchSEA. "Researchers regenerate a fully functional bioengineered lacrimal gland." ScienceDaily. www.sciencedaily.com/releases/2013/10/131002102315.htm (accessed September 22, 2014).

Share This



More Health & Medicine News

Monday, September 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Liberia Pleads for Help to Fight Ebola

Liberia Pleads for Help to Fight Ebola

AP (Sep. 22, 2014) Liberia's finance minister is urging the international community to quickly follow through on pledges of cash to battle Ebola. Bodies are piling up in the capital Monrovia as the nation awaits more help. (Sept. 22) Video provided by AP
Powered by NewsLook.com
Ebola Doctor Says Border Controls Critical

Ebola Doctor Says Border Controls Critical

AP (Sep. 22, 2014) A Florida doctor who helped fight the expanding Ebola outbreak in West Africa says the disease can be stopped, but only if nations quickly step up their response and make border control a priority. (Sept. 22) Video provided by AP
Powered by NewsLook.com
Global Ebola Aid Increasing But Critics Say It's Late

Global Ebola Aid Increasing But Critics Say It's Late

Newsy (Sep. 21, 2014) More than 100 tons of medical supplies were sent to West Africa on Saturday, but aid workers say the global response is still sluggish. Video provided by Newsy
Powered by NewsLook.com
Sierra Leone in Lockdown to Control Ebola

Sierra Leone in Lockdown to Control Ebola

AP (Sep. 21, 2014) Sierra Leone residents remained in lockdown on Saturday as part of a massive effort to confine millions of people to their homes in a bid to stem the biggest Ebola outbreak in history. (Sept. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins